Home › Funds › Boston Partners › AZN

Boston Partners position in AZN

ASTRAZENECA PLC · Health Care

Boston Partners reported holding 4,173,787 shares of AZN (ASTRAZENECA PLC) in its Q3 2026 13F filing — a position valued at US$673.4M, representing 0.61% of its reported portfolio and ranking #46 among its reported holdings. Boston Partners has disclosed AZN holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)4.17M sh
Reported value held$673.41M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Partners's AZN position evolved

Boston Partners first disclosed a stake in AZN in Q3 2023 at 3,107 shares (US$210K). The position peaked in Q3 2026 at 4,173,787 shares, worth US$673.4M. Across 12 filings, Boston Partners increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,173,787 shares valued at US$673.4M — an increase of 996,160 shares quarter over quarter.. Notable position changes include a 832% increase in Q3 2024 (shares fell 16% over the following quarter), a 9986% increase in Q4 2024 (shares rose 14% over the following quarter), a 52% increase in Q2 2026 (shares fell 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.11K $210.41K New
Q1 2024 4.49K $308.58K New
Q2 2024 3.95K $308.72K Reduce
Q3 2024 36.76K $2.86M Add
Q4 2024 3.71M $243.44M Add
Q1 2025 5.04M $368.71M Add
Q2 2025 4.99M $349.92M Reduce
Q3 2025 5.25M $405.05M Add
Q4 2025 4.23M $389.45M Reduce
Q1 2026 2.09M $413.45M Reduce
Q2 2026 3.18M $597.39M Add
Q3 2026 4.17M $673.41M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AZN and 13F data

AZN (ASTRAZENECA PLC) is a Health Care company. 64 other funds we track also report a position in AZN — the largest reported positions include INVESTOR AB (US$9.78B), Norges Bank Investment Management (US$6.33B), Capital World Investors (US$5.63B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AZN

All AZN fund holders →

FAQ

How long has Boston Partners held AZN?

Boston Partners has disclosed AZN holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Partners's current position in AZN?

As of Q3 2026, Boston Partners holds 4.17M shares of AZN (ASTRAZENECA PLC), valued at $673.41M, representing 0.61% of its reported portfolio and ranking #46.

Has Boston Partners been buying or selling AZN?

In the latest 13F filing (Q3 2026), Boston Partners increased its position in AZN. The position peaked in Q3 2026 at 4.17M shares.

Which other funds hold AZN?

Other major institutional holders of AZN include INVESTOR AB, Norges Bank Investment Management, Capital World Investors, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.